BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 2594991)

  • 1. [Usefulness of determining serum levels of prolactin in women with menstruation disorders].
    Starzewski J; Niespodziański K; Kowalski D; Kowalska K; Piasek G; Chlewicka B
    Przegl Lek; 1989; 46(10):728-31. PubMed ID: 2594991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine-induced changes in serum prolactin in women with oligomenorrhea, amenorrhea, and pituitary adenoma.
    Archer DF; Josimovich JB; Maroon JC
    Fertil Steril; 1977 Nov; 28(11):1164-7. PubMed ID: 923833
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of endocrinologic diagnosis in sterility patients. A clinical report of experiences].
    Melzer H; Uhlmann G
    Zentralbl Gynakol; 1985; 107(16):989-95. PubMed ID: 3931388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An endocrinological study of hyperprolactinemia and its treatment (author's transl)].
    Kimura T; Narita O; Suzuki M; Tomoda Y; Kuwayama A; Kageyama N
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):784-92. PubMed ID: 6787150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variations of the plasma levels of gonadotrophins (FSH and LH) and of its response to stimulation with gonadotrophin releasing hormone (GnRH) with different plasma levels of prolactin (PRL) in women with the syndrome of galactorrhea-amenorrhea (author's transl)].
    Salmerón de Diego J; Alonso Rodríguez C; Santos Reyero M; Salazar Orlando A; Palacios Mateos JM
    Med Clin (Barc); 1981 Feb; 76(4):164-8. PubMed ID: 6782394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperprolactinemia and disorders of the menstrual cycle].
    Topalski-Fistes N; Bujas M; Maticki-Sekulić M; Suvacarev S
    Med Pregl; 1999; 52(3-5):156-61. PubMed ID: 10518402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of galactorrhea in patients with normal menses, oligomenorrhea, and secondary amenorrhea.
    Davajan V; Kletzky O; March CM; Roy S; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(8):894-904. PubMed ID: 565142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary microadenoma and hyperprolactinemia: a cause of unexplained secondary amenorrhea.
    Boyar RM; Kapen S; Weitzman ED; Hellman L
    N Engl J Med; 1976 Jan; 294(5):263-5. PubMed ID: 811989
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperprolactinemia and associated pituitary prolactinomas.
    Brenner SH; Lessing JB; Quagliarello J; Weiss G
    Obstet Gynecol; 1985 May; 65(5):661-4. PubMed ID: 4039046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
    Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
    Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactorrhea-amenorrhea and hyperprolactinemia associated with pituitary tumors of growth-hormone- and adrenocorticotropic-hormone-secreting cells. A report of two cases.
    Haney AF; McCarty KS; Hammond CB
    J Reprod Med; 1984 Dec; 29(12):883-7. PubMed ID: 6097688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia.
    Badawy SZ; Nusbaum ML; Omar M
    Obstet Gynecol; 1980 Jan; 55(1):1-7. PubMed ID: 6243406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
    van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
    Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amenorrhoea and hyperprolactinaemia (author's transl)].
    Tscherne G
    Wien Klin Wochenschr; 1979 Dec; 91(23):790-3. PubMed ID: 543141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution to the problem of hyperprolactinaemia: experience with 4,199 prolactin assays and 117 prolactinomas.
    Batrinos ML; Panitsa-Faflia C; Tsiganou E; Pitoulis G; Liapi C
    Int J Fertil Menopausal Stud; 1994; 39(2):120-7. PubMed ID: 8012441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.